期刊文献+

低浓度5-氟尿嘧啶对胃癌细胞生物学特性的影响

Effects of low level of 5-fluorouracil on biological characteristics of gastric cancer cell lines
下载PDF
导出
摘要 目的探讨低浓度5-氟尿嘧啶(5-FU)对胃癌细胞转录因子OCT4、SOX2及细胞增殖能力的影响。方法用MTT法检测并确定5-FU对胃癌细胞系MGC803、SGC-7901的半数抑制浓度(IC50),实时荧光定量PCR及western blot检测经不同浓度的5-FU处理后胃癌细胞转录因子OCT4、SOX2表达水平,平板克隆形成实验分析胃癌细胞增殖能力的改变情况。结果5-FU对MGC803、SGC-7901细胞的IC50分别为(28.82±1.25)和(23.95±1.34);低浓度5-FU(0.5、1μmol/L)处理后,胃癌细胞MGC803、SGC-7901中转录因子OCT4、SOX2在mRNA及蛋白质水平中的表达均增强,差异具有统计学意义(P<0.05);平板克隆形成实验结果表明,经低浓度5-FU(0.5、1μmol/L)作用后胃癌细胞的增殖能力变强,形成的克隆数增多,差异有统计学意义(P<0.05);但5-FU浓度为2μmol/L时OCT4和SOX4的表达有不同程度的减弱,且克隆形成能力也有下降。结论低浓度5-FU能增强胃癌细胞转录因子表达、促进胃癌细胞增殖。 Objective To explore the effects of low level of 5-fluorouracil( 5-FU) on biological characteristics of gastric cancer cell lines. Methods The half inhibition concentration( IC50) of gastric cancer cells was detected by MTT assay. qRT-PCR and western blot were applied to determine the effects of different concentration of 5-FU level of transcription factor OCT4 and SOX2 expression in gastric cancer cells. Colony formation assay was used to analyze the growth ability of gastric cancer cells treated with low level of 5-FU.Results MTT assay showed that the IC50 of MGC803 and SGC-7901 were 28. 82 ± 1. 25 and 23. 95 ± 1. 34 respectively. qRT-PCR and western blot revealed that low level of 5-FU( 0. 5μmol / L、1μmol / L) enhanced the stemness of gastric cancer cells. At mRNA and protein level,the expression of OCT4 and SOX2 were upregulated than control group in MGC803 and SGC-7901 cells,showing significant difference. Colony formation assay showed that low level of 5-FU( 0. 5 μmol / L、1 μmol / L) could obviously promote gastric cancer cells growth. When the level of 5-FU to achieve 2 μmol / L,the expression of OCT4 and SOX2 were downregulated than control group in MGC803 and SGC-7901 cells,and colony formation assay showed inhibit gastric cancer cells growth. Conclusion Our results indicate that low level of 5-FU enhanced gastric cancer cells transcription factor expression,and promoted proliferation.
出处 《临床检验杂志》 CAS CSCD 2016年第3期182-185,共4页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金(81572075) 江苏省社会发展面上项目(BE2015667) 江苏省普通高校研究生科研创新计划项目(KYLX_1075) 江苏省检验医学重点实验室开放课题(JSKLM-2014-004)
关键词 胃癌细胞 5-氟尿嘧啶 低浓度 转录因子 gastric cancer cells 5-FU low level transcription factor
  • 相关文献

参考文献2

二级参考文献24

  • 1Wei-guo Zhu,Da-fu Xua,Jun Pu,Cheng-dong Zong,Tao Li,Guang-zhou Tao,Fu-zhi Ji,Xi-lei Zhou,Ji-hua Han,Cheng-shi Wang,Chang-hua Yu,Jiang-guo Yi,Xi-long Su,Jin-xia Ding.A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection[J]. Radiotherapy and Oncology . 2012 (3)
  • 2Macdonald J S,Smalley S R,Benedetti J,et al.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. The New England Journal of Medicine . 2001
  • 3Ychou Marc,Boige Valérie,Pignon Jean-Pierre,Conroy Thierry,Bouché Olivier,Lebreton Gilles,Ducourtieux Muriel,Bedenne Laurent,Fabre Jean-Michel,Saint-Aubert Bernard,Genève Jean,Lasser Philippe,Rougier Philippe.Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2011
  • 4Stephen R. Smalley,Jacqueline K. Benedetti,Daniel G. Haller,Scott A. Hundahl,Norman C. Estes,Jaffer A. Ajani,Leonard L. Gunderson,Bryan Goldman,James A. Martenson,J. Milburn Jessup,Grant N. Stemmermann,Charles D. Blanke,John S. Macdonald.Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection[J].Journal of Clinical Oncology.2012(19)
  • 5Florian Lordick,Yoon-Koo Kang,Hyun-Cheol Chung,Pamela Salman,Sang Cheul Oh,Gy?rgy Bodoky,Galina Kurteva,Constantin Volovat,Vladimir M Moiseyenko,Vera Gorbunova,Joon Oh Park,Akira Sawaki,Ilhan Celik,Heiko G?tte,Helena Melezínková,Markus Moehler.Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6)
  • 6Koji Oba,Xavier Paoletti,Steven Alberts,Yung-Jue Bang,Jacqueline Benedetti,Harry Bleiberg,Paul Catalano,Florian Lordick,Stefan Michiels,Satoshi Morita,Yasuo Ohashi,Jean-pierre Pignon,Philippe Rougier,Mitsuru Sasako,Junichi Sakamoto,Daniel Sargent,Kohei Shitara,Eric Van Cutsem,Marc Buyse,Tomasz Burzykowski.Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis[J].JNCI Journal of the National Cancer Institute.2013(21)
  • 7Alexandre Andrade Anjos Jácome,Durval R. Wohnrath,Cristovam Scapulatempo Neto,Estela C. Carneseca,Sérgio V. Serrano,Luciano Souza Viana,Jo?o S. Nunes,Edson Z. Martinez,José Sebasti?o Santos.Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors[J].Gastric Cancer.2014(1)
  • 8Eun-Jung Jung,Eun-Ji Jung,Sun Young Min,Min A Kim,Woo Ho Kim.Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma[J].Human Pathology.2012(10)
  • 9Uemura N,Okamoto S,Yamamoto S,Matsumura N,Yamaguchi S,Yamakido M,Taniyama K,Sasaki N,Schlemper R J.Helicobacter pylori infection and the development of gastric cancer. The New England Quarterly . 2001
  • 10Blume-Jensen P,Hunter T.Oncogenic kinase signalling. Nature . 2001

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部